author-photo

M. Poudenx

French Institute of Health and Medical Research

76

Papers

2030

Citations

Citation Trend

Filter By

Papers (54) Sort By

Journal Conference Others

Real-world assessment of the BRAF status in non-squamous cell lung carcinoma using VE1 immunohistochemistry: A single laboratory experience (LPCE, Nice, France).

2020 Lung Cancer
Show All
- Source
- Cite
- Save
Citations (3)
Occurrence and number of immune-related adverse events are independently associated with survival in advanced non-small-cell lung cancer treated by nivolumab.

2020 Bulletin Du Cancer
Show All
- Source
- Cite
- Save
Citations (4)
Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution.

2020 Journal of Translational Medicine
Show All
- Source
- Cite
- Save
Citations (4)
Outcomes of advanced Non-Small Cell Lung Cancer patients From the IFCT Biomarkers France study by KRAS Mutation Subtypes

2020
Show All
- Source
- Cite
- Save
Citations (1)
Baseline metabolic tumor volume as a strong predictive and prognostic biomarker in patients with non-small cell lung cancer treated with PD1 inhibitors: a prospective study

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (15)
18FDG PET/CT in the early assessment of non-small cell lung cancer response to immunotherapy: frequency and clinical significance of atypical evolutive patterns

2019 European Journal of Nuclear Medicine and Molecular Imaging
Show All
- Source
- Cite
- Save
Citations (29)
In-house Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-small Cell Lung Cancer and Melanoma Patients

2019 Cancers
Show All
- Source
- Cite
- Save
Citations (15)
Abstract 4889: Comparison of tumor mutational burden using the Ion Oncomine™ TML and FoundationOne™ assays with routine clinical FFPE tissue samples to predict durable clinical benefit in lung cancer and melanoma patients - a multivariate analysis integrating PD-L1 and CD8+evaluation

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 3127: Multicenter study evaluating the ROS1 status in lung adenocarcinoma using the novel SP384 immunohistochemistry clone. Towards a new algorithm for ROS1 status assessment in routine

2019 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Critical assessment in routine clinical practice of liquid biopsy for EGFR status testing in Non-Small Cell Lung Cancer – A single laboratory experience (LPCE, Nice, France)

2019 Clinical Lung Cancer
Show All
- Source
- Cite
- Save
Citations (10)